Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 788

The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.

Ionotropic and metabotropic glutamate receptor structure and pharmacology

Kew, James N. C., Kemp, John A.·2005·Psychopharmacology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00213-005-2200-z

Cites

219 of 219 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 219 references

Research works printed but not linked: 23

  1. Ahmadian H, Nielsen B, Brauner-Osborne H, Johansen TN, Stensbol TB, Slok FA, Sekiyama N, Nakanishi S, Krogsgaard-Larsen P, Madsen U (1997) (S)-Homo-AMPA, a specific agonist at the mGlu6 subtype of metabotropic glutamic acid receptors. J Med Chem 40:3700?3705 · doi:10.1021/jm9703597
  2. Bräuner-Osborne H, Krogsgaard-Larsen P (1998) Pharmacology of (S)-homoquisqualic acid and (S)-2-amino-5-phosphopentanoic acid [(S)-AP5] at cloned metabotropic glutamate receptors. Br J Pharmacol 123:269?274 · DOI
  3. Bristow LJ, Hutson PH, Kulagowski JJ, Leeson PD, Matheson S, Murray F, Rathbone D, Saywell KL, Thorn L, Watt AP, Tricklebank MD (1996) Anticonvulsant and behavioral profile of l-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-d-aspartate receptor complex. J Pharmacol Exp Ther 279:492?501
  4. Brown JC, Tse HW, Skifter DA, Christie JM, Andaloro VJ, Kemp MC, Watkins JC, Jane DE, Monaghan DT (1998) [3H]Homoquinolinate binds to a subpopulation of NMDA receptors and to a novel binding site. J Neurochem 71:1464?1470 · doi:10.1046/j.1471-4159.1998.71041464.x
  5. Chenard BL, Menniti FS, Pagnozzi MJ, Shenk KD, Ewing FE, Welch WM (2000) Methaqualone derivatives are potent noncompetitive AMPA receptor antagonists. Bioorg Med Chem Lett 10:1203?1205 · doi:10.1016/s0960-894x(00)00216-x
  6. Di Fabio R, Capelli AM, Conti N, Cugola A, Donati D, Feriani A, Gastaldi P, Gaviraghi G, Hewkin CT, Micheli F, Missio A, Mugnaini M, Pecunioso A, Quaglia AM, Ratti E, Rossi L, Tedesco G, Trist DG, Reggiani A (1997) Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site. J Med Chem 40:841?850 · doi:10.1021/jm960644a
  7. Huang D, Poon SF, Chapman DF, Chung J, Cramer M, Reger TS, Roppe JR, Thehrani L, Cosford NDP, Smith ND (2004) 2-(2-[3-(Pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl) pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist. Bioorg Med Chem Lett 14:5473?5476 · doi:10.1016/j.bmcl.2004.09.012
  8. Kohara A, Okada M, Tsutsumi R, Ohno K, Takahashi M, Shimizu-Sasamata M, Shishikura J, Inami H, Sakamoto S, Yamaguchi T (1998) In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist. J Pharm Pharmacol 50:795?801 · doi:10.1111/j.2042-7158.1998.tb07142.x
  9. Langan YM, Lucas R, Jewell H, Toublanc N, Schaefer H, Sander JWAS, Patsalos PN (2003) Talampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy. Epilepsia 44:46?53 · doi:10.1046/j.1528-1157.2003.128902.x
  10. Levine LR, Gaydos B, Sheehan D, Goddard A, Feighner J, Potter WZ, Schoepp DD (2001) The mGlu2/3 receptor agonist, LY354740, reduces panic anxiety induced by CO2 challenge in patients diagnosed with panic disorder. Neuropharmacology 43:294
  11. Nahum-Levy R, Fossom LH, Skolnick P, Benveniste M (1999) Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-d-aspartate receptors. Mol Pharmacol 56:1207?1218 · doi:10.1124/mol.56.6.1207
  12. Ohtani K, Tanaka H, Yoneda Y, Yasuda H, Ito A, Nagata R, Nakamura M (2002) In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site. Brain Res 944:165?173 · doi:10.1016/s0006-8993(02)02741-5
  13. Pellicciari R, Luneia R, Costantino G, Marinozzi M, Natalini B, Jakobsen P, Kanstrup A, Lombardi G, Moroni F, Thomsen C (1995) 1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors. J Med Chem 38:3717?3719 · doi:10.1021/jm00019a002
  14. Rowley M, Kulagowski JJ, Watt AP, Rathbone D, Stevenson GI, Carling RW, Baker R, Marshall GR, Kemp JA, Foster AC, Grimwood S, Hargreaves R, Hurley C, Saywell KL, Tricklebank MD, Leeson PD (1997) Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists. J Med Chem 40:4053?4068 · doi:10.1021/jm970417o
  15. Schoepp DD, Monn JA, Marek GJ, Aghajanian G, Moghadam B (1999b) LY354740: a systemically active mGlu2/mGlu3 receptor agonist. CNS Drug Rev 5:1?12 · doi:10.1111/j.1527-3458.1999.tb00082.x
  16. Shigemoto R, Mizuno N (2000) Metabotropic glutamate receptors-immunocytochemical and in situ hybridisation analysis. In: Ottersen OP, Storm-Mathisen J (eds) Handbook of chemical neuroanatomy 18: glutamate. Elsevier, Amsterdam, pp 63?98
  17. Smith ND, Poon SF, Huang D, Green M, King C, Tehrani L, Roppe JR, Chung J, Chapman DP, Cramer M, Cosford ND (2004) Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity. Bioorg Med Chem Lett 14:5481?5484 · doi:10.1016/j.bmcl.2004.09.018
  18. Suzuki Y, Moriyoshi E, Tsuchiya D, Jingami H (2004) Negative cooperativity of glutamate binding in the dimeric metabotropic glutamate receptor subtype 1. J Biol Chem 279:35526?35534 · DOI
  19. Szabados T, Gigler G, Gacsalyi I, Gyertyan I, Levay G (2001) Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655. Brain Res Bull 55:387?391 · doi:10.1016/s0361-9230(01)00516-0
  20. Tarnawa I, Bersenyi P, Andrasi F, Botka P, Hamori T, Ling I, Korosi J (1993) Structure?activity relationships of 2,3-benzodiazepine compounds with glutamate antagonistic action. Bioorg Med Chem Lett 3:99?104 · doi:10.1016/s0960-894x(00)80100-6
  21. Thomas NK, Wright RA, Howson PA, Kingston AE, Schoepp DD, Jane DE (2001) (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neurophamacology 40:311?318 · doi:10.1016/s0028-3908(00)00169-6
  22. Thomsen C, Boel E, Suzdak PD (1994) Actions of phenylglycine analogs at subtypes of the metabotropic glutamate receptor family. Eur J Pharmacol 267:77?84 · DOI
  23. Zhou ZL, Kher SM, Cai SX, Whittemore ER, Espitia SA, Hawkinson JE, Tran M, Woodward RM, Weber E, Keana JF (2003) Synthesis and SAR of novel di- and trisubstituted 1,4-dihydroquinoxaline-2,3-diones related to licostinel (Acea 1021) as NMDA/glycine site antagonists. Bioorg Med Chem 11:1769?1780 · doi:10.1016/s0968-0896(03)00059-2

Cited by

See all 788

Metadata

Authors
Kew, J. N. C., & Kemp, J. A.
Venue
Psychopharmacology
Published
2005-02-25
Volume
179
Issue
1
Pages
4-29
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2122532139
Cited by
788
References
219
FWCI
17.10
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ionotropic and metabotropic glutamate receptor structure and pharmacology. https://app.cochat.ai/papers/10.1007/s00213-005-2200-z
The paper
Kew, J. N. C., & Kemp, J. A. (2005). Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology. https://doi.org/10.1007/s00213-005-2200-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.